health - "cancer"

HealthDay - FRIDAY, July 3 (HealthDay News) -- The new vaccine vitespendidn't increase recurrence-free survival among kidney cancer patientswho'd had surgery, say U.S. researchers.

A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday.

Main Category: cancer / Oncology Also Included In: Liver Disease / Hepatitis Article Date: 03 Jul 2008 - 4:00 PDT printer friendly view / write opinions rate article More than 170 physicians and health care ...

Thursday, 3 July 2008, 3:24 pm Press Release: Ascot Radiology 3 JULY 2008 What was once the most difficult part of breast cancer diagnosis, involving significant guesswork, has now become an exact science ...

The growing number of cancer treatment options and their widely varying costs suggest an increased need for oncologists to understand economic issues in cancer care and be able to discuss these issue with their ...

A study by an international team of researchers found that an experimental drug that stops blood vessels that feed tumors from forming was able, in a small number of patients, to slow down the progression of advanced thyroid cancer that has spread to other sites.

Two newspapers on Tuesday published articles related to breast cancer detection and surgery. Summaries appear below.~ AP/Washington Post: The AP/Post examined two experimental technologies that aim to improve breast cancer detection among women with dense breasts.

Women who are at high risk for breast cancer may want to consider passing up an MRI for a newer, less expensive diagnostic test.

IntroductionA number of breast cancer risk prediction models have been developed to provide insight into a woman's individual breast cancer risk. Although circulating levels of estradiol in postmenopausal women predict subsequent breast cancer risk, whether the addition of estradiol levels adds significantly to a model's predictive power has not previously been evaluated.Methods:Using linear regression, the authors developed an imputed estradiol score using measured estradiol levels (the outcome) and both case status and risk factor data (e.g., body mass index) from a nested case-control study conducted within a large prospective cohort study and used multiple imputation methods to develop an overall risk model including both risk factor data from the main cohort and estradiol levels from the nested case-control study.Results:The authors evaluated the addition of imputed estradiol level to the previously published Rosner and Colditz log incidence model for breast cancer risk predi

The number of people surviving some of the most common types of cancer for at least five years has doubled since the National health Service was founded 60 years ago.